EDWARD BARSEGYAN: Open Payments
NPI 1407624927 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 18 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $171 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 11 | $298 |
| ABBVIE INC. | 4 | $78 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: DOVATO, CABENUVA, VRAYLAR, PIFELTRO, APRETUDE, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
